PharmEasy launches WomenCare category for women's health
By Abha Lohia · Editor ·
PharmEasy: funding and every story →
Founded 2019
- PharmEasy is an online platform for medicines, lab tests, and doctor consultations
- It launched the WomenCare category with exclusive offers on International Women's Day
- The category covers sexual wellness, fertility, and PCOD with curated health packages
What happened
- PharmEasy has launched a new category called WomenCare focused on women's health.
- This launch coincides with International Women's Day exclusive offers for customers.
- The platform aims to be a one-stop destination for various women's healthcare needs.
- WomenCare supports users across different life stages from adolescence to maternity.
- The initiative provides a judgment-free space for accessing essential health information.
- Gaurav Verma leads the business strategy behind this new healthcare vertical.
- Verma stated the goal is to make proactive healthcare simpler and affordable.
- The company plans to add additional segments to the WomenCare category soon.
Why it matters
- PharmEasy targets underserved niches within digital health through specialized categories.
- Launching during International Women's Day highlights a focus on gender-specific care.
- The move signals expansion beyond basic medicine delivery into holistic wellness.
- Competitors are increasingly segmenting their offerings to capture specific demographics.
The business
- Users can order medicines by uploading prescriptions for doorstep delivery.
- The platform offers lab tests and online doctor consultations starting at ₹199.
- Customers access health blogs and value store items alongside medical products.
- Featured categories include vitamins, supplements, and personal care essentials.
- PharmEasy serves over 50 Lakhs active customers across India.
- Prescription workflow involves photo upload, address addition, and confirmation calls.
- App-only offers provide up to 25% off on orders above ₹1,000.
- Branded substitutes and healthcare devices are available for purchase.
- Specialized stores exist for diabetes, ayurvedic care, and elderly mobility.
The founders
In numbers
50 Lakhs+Customers
₹199Doctor Consultation Starting Price
25%First Order Discount
What happens next
- PharmEasy plans to introduce additional segments to the WomenCare category.
- The company will continue expanding its range of health-focused services.
Words to know
- PCOD
- Polycystic Ovary Disease, a hormonal disorder common in women of reproductive age.
- Lab Tests
- Medical examinations of blood or tissue samples to diagnose conditions.
The numbers around it
Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →
Read next
Stake saleAPI Holdings sells Thyrocare stake, repays debtAPI Holdings runs PharmEasy, an online pharmacy, and Thyrocare, a diagnostics chainFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on PharmEasy → · All startup news on 6 March 2026 →
Is this PharmEasy? Get your “Featured on StopDown” badge →